SCHEMBL19251687

SCHEMBL19251687

CCOC(=O)CC(=O)N(Cc1ccc(C(F)(F)F)cc1)C1=C(C(=O)OCC)CC(=O)N(C)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.38
▸ CETP P11597 2/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ KDM4E B2RXH2 4/20 0.37
▸ EPHX2 P34913 1/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ FPR2 P25090 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ TRPM2 O94759 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ AGTR1 P30556 1/20 0.34
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629585 0.85 CETP (0.43) PPARGCETPALDH1A1KDM4EMEN1
SCHEMBL17629592 0.77 KCNQ2 (0.43) PPARGALDH1A1KDM4EEPHX2MEN1
SCHEMBL19251713 0.77 TLR2 (0.39) PPARGCETPALDH1A1KDM4EEPHX2
SCHEMBL19251699 0.76 MAPT (0.39) CETPALDH1A1KDM4EMEN1KMT2A
SCHEMBL17629532 0.75 ALDH1A1 (0.37) PPARGCETPALDH1A1KDM4EEPHX2
SCHEMBL941008 0.75 CETP (0.38) PPARGCETPALDH1A1KDM4EEPHX2
SCHEMBL17629533 0.75 TRPM2 (0.36) PPARGCETPALDH1A1KDM4EEPHX2
SCHEMBL17629556 0.74 PPARG (0.35) PPARGCETPEPHX2MAPTTRPM2
SCHEMBL17629564 0.70 PPARG (0.35) PPARGCETPALDH1A1KDM4EEPHX2
SCHEMBL17629562 0.70 CACNA1F (0.36) PPARGCETPALDH1A1KDM4EEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197455-B1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME (US) 2020-12-30 — — EP disclosed
US-10000501-B2 Inhibitors of HIF prolyl hydroxylase MERCK SHARP & DOHME CORP. (US) 2018-06-19 — — US disclosed
US-20170240555-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10000501-B2 Inhibitors of HIF prolyl hydroxylase HIF1AN, HIF1A, EGLN2 PPARG 741/4885CETP 2105/4885ALDH1A1 348/4885
US-20170240555-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE HIF1AN, HIF1A, EGLN2 PPARG 741/4885CETP 2105/4885ALDH1A1 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback